[The clinico-immunological evaluation of the ribomunyl treatment of chronic bronchitis patients]. 1994

A M Borisova, and N V Khoroshilova, and B V Pinegin, and O F Eremina, and A V Simonova, and A V Kulakov, and N M Golubeva, and I I Dykhanov

The paper reports the results of ribomunil trial in chronic bronchitis (CB) patients who suffered from frequent exacerbations. The drug was found to act primarily on a phagocytic component of the immunity and local immunity of the respiratory mucosa. Because of its vaccine-like effect, ribomunil administration is most beneficial in CB remission. Ribomunil treatment results in reduction of the number and duration of CB exacerbations, of the scope of antibacterial therapy.

UI MeSH Term Description Entries
D007111 Immunity, Cellular Manifestations of the immune response which are mediated by antigen-sensitized T-lymphocytes via lymphokines or direct cytotoxicity. This takes place in the absence of circulating antibody or where antibody plays a subordinate role. Cell-Mediated Immunity,Cellular Immune Response,Cell Mediated Immunity,Cell-Mediated Immunities,Cellular Immune Responses,Cellular Immunities,Cellular Immunity,Immune Response, Cellular,Immune Responses, Cellular,Immunities, Cell-Mediated,Immunities, Cellular,Immunity, Cell-Mediated,Response, Cellular Immune
D008875 Middle Aged An adult aged 45 - 64 years. Middle Age
D010919 Placebos Any dummy medication or treatment. Although placebos originally were medicinal preparations having no specific pharmacological activity against a targeted condition, the concept has been extended to include treatments or procedures, especially those administered to control groups in clinical trials in order to provide baseline measurements for the experimental protocol. Sham Treatment
D001991 Bronchitis Inflammation of the large airways in the lung including any part of the BRONCHI, from the PRIMARY BRONCHI to the TERTIARY BRONCHI. Bronchitides
D002908 Chronic Disease Diseases which have one or more of the following characteristics: they are permanent, leave residual disability, are caused by nonreversible pathological alteration, require special training of the patient for rehabilitation, or may be expected to require a long period of supervision, observation, or care (Dictionary of Health Services Management, 2d ed). For epidemiological studies chronic disease often includes HEART DISEASES; STROKE; CANCER; and diabetes (DIABETES MELLITUS, TYPE 2). Chronic Condition,Chronic Illness,Chronically Ill,Chronic Conditions,Chronic Diseases,Chronic Illnesses,Condition, Chronic,Disease, Chronic,Illness, Chronic
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000276 Adjuvants, Immunologic Substances that augment, stimulate, activate, potentiate, or modulate the immune response at either the cellular or humoral level. The classical agents (Freund's adjuvant, BCG, Corynebacterium parvum, et al.) contain bacterial antigens. Some are endogenous (e.g., histamine, interferon, transfer factor, tuftsin, interleukin-1). Their mode of action is either non-specific, resulting in increased immune responsiveness to a wide variety of antigens, or antigen-specific, i.e., affecting a restricted type of immune response to a narrow group of antigens. The therapeutic efficacy of many biological response modifiers is related to their antigen-specific immunoadjuvanticity. Immunoactivators,Immunoadjuvant,Immunoadjuvants,Immunologic Adjuvant,Immunopotentiator,Immunopotentiators,Immunostimulant,Immunostimulants,Adjuvant, Immunologic,Adjuvants, Immunological,Immunologic Adjuvants,Immunological Adjuvant,Adjuvant, Immunological,Immunological Adjuvants
D000293 Adolescent A person 13 to 18 years of age. Adolescence,Youth,Adolescents,Adolescents, Female,Adolescents, Male,Teenagers,Teens,Adolescent, Female,Adolescent, Male,Female Adolescent,Female Adolescents,Male Adolescent,Male Adolescents,Teen,Teenager,Youths
D000328 Adult A person having attained full growth or maturity. Adults are of 19 through 44 years of age. For a person between 19 and 24 years of age, YOUNG ADULT is available. Adults
D000917 Antibody Formation The production of ANTIBODIES by proliferating and differentiated B-LYMPHOCYTES under stimulation by ANTIGENS. Antibody Production,Antibody Response,Antibody Responses,Formation, Antibody,Production, Antibody,Response, Antibody,Responses, Antibody

Related Publications

A M Borisova, and N V Khoroshilova, and B V Pinegin, and O F Eremina, and A V Simonova, and A V Kulakov, and N M Golubeva, and I I Dykhanov
January 1998, Terapevticheskii arkhiv,
A M Borisova, and N V Khoroshilova, and B V Pinegin, and O F Eremina, and A V Simonova, and A V Kulakov, and N M Golubeva, and I I Dykhanov
January 2005, Klinicheskaia meditsina,
A M Borisova, and N V Khoroshilova, and B V Pinegin, and O F Eremina, and A V Simonova, and A V Kulakov, and N M Golubeva, and I I Dykhanov
March 1983, Vrachebnoe delo,
A M Borisova, and N V Khoroshilova, and B V Pinegin, and O F Eremina, and A V Simonova, and A V Kulakov, and N M Golubeva, and I I Dykhanov
January 1985, Terapevticheskii arkhiv,
A M Borisova, and N V Khoroshilova, and B V Pinegin, and O F Eremina, and A V Simonova, and A V Kulakov, and N M Golubeva, and I I Dykhanov
October 1976, Vestnik dermatologii i venerologii,
A M Borisova, and N V Khoroshilova, and B V Pinegin, and O F Eremina, and A V Simonova, and A V Kulakov, and N M Golubeva, and I I Dykhanov
August 1992, Likars'ka sprava,
A M Borisova, and N V Khoroshilova, and B V Pinegin, and O F Eremina, and A V Simonova, and A V Kulakov, and N M Golubeva, and I I Dykhanov
March 1983, Vestnik dermatologii i venerologii,
A M Borisova, and N V Khoroshilova, and B V Pinegin, and O F Eremina, and A V Simonova, and A V Kulakov, and N M Golubeva, and I I Dykhanov
March 1985, Vrachebnoe delo,
A M Borisova, and N V Khoroshilova, and B V Pinegin, and O F Eremina, and A V Simonova, and A V Kulakov, and N M Golubeva, and I I Dykhanov
January 1988, Terapevticheskii arkhiv,
A M Borisova, and N V Khoroshilova, and B V Pinegin, and O F Eremina, and A V Simonova, and A V Kulakov, and N M Golubeva, and I I Dykhanov
January 1985, Terapevticheskii arkhiv,
Copied contents to your clipboard!